For the Inventor, By the Inventor

Enter inventor name

Princeton, NJ, United States of America

Alexey Ryazanov

USPTO Granted Patents = 8 (Patent Applications = 4)

Average Co-Inventor Count = 1.5

ph-index = 2

Forward Citations = 9(Granted Patents)

Company Filing History:

University of Medicine and Dentistry of New Jersey

Rutgers, the State University of New Jersey

Longevica Therapeutics Inc.

Years Active: 2002-2020

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10653715 - Methods and compositions for extending lifespan (2020-05-19),

2. 8916379 - Mammalian alpha-kinase proteins, nucleic acids and diagnostic and therapeutic uses thereof (2014-12-23),

3. 8604163 - EEF2K assays for identifying compounds that inhibit EEF2K activity (2013-12-10),

4. 8349576 - eEF2K assays for identifying compounds that inhibit eEF2K activity (2013-01-08),

5. 8030286 - Methods and means for increasing resistance to cell damage (2011-10-04),

6. 7785878 - Mammalian alpha-kinase proteins, nucleic acids and diagnostic and therapeutic uses thereof (2010-08-31),

7. 7087427 - Mammalian alpha-kinase proteins, nucleic acids and diagnostic and therapeutic uses thereof (2006-08-08),

8. 6346406 - Elongation factor-2 kinase (EF-2 kinase), and methods of use therefor (2002-02-12),

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…